ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
ImmunityBio Inc

ImmunityBio Inc (IBRX)

6,92
-0,37
(-5,08%)
Geschlossen 06 Juni 10:00PM
6,91
-0,01
( -0,14% )
Vor Marktöffnung: 10:20AM

ImmunityBio Inc (IBRX) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
6,91
( -0,14% )
Gebot
6,91
Fragen
7,05
Volumen
4.448
0,00 Tagesbereich 0,00
1,95 52-Wochen-Bereich 12,28
Marktkapitalisierung
Handelsende
6,92
Handelsbeginn
-
Letzte Trade
1
@
6.88
Letzter Handelszeitpunkt
10:20:54
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 18.305.656
Ausgegebene Aktien
1.047.353.977
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-8,09
Gewinn pro Aktie (EPS)
-0,89
Erlöse (LTM)
140,98M
Nettogewinn (LTM)
-854,53M

Über ImmunityBio Inc

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic pro... ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company’s platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
San Diego, United States
Gegründet
-
ImmunityBio Inc is listed in the Healthcare sector of the NASDAQ with ticker IBRX. The last closing price for ImmunityBio was US$6,92. Over the last year, ImmunityBio shares have traded in a share price range of US$ 1,95 to US$ 12,28.

ImmunityBio currently has 1.047.353.977 shares in issue. The market capitalisation of ImmunityBio is US$7,24 billion. ImmunityBio has a price to earnings ratio (PE ratio) of -8.09.

Option-Flow ImmunityBio (IBRX)

Gesamtfluss

Bullisch

Nettoprämie

4M

Calls / Puts

833,33%

Käuf. / Verkä.

32,08%

OTM / ITM

68,00%

Sweeps

0,00%

IBRX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.48-6.495263870097.397.5156.7945132824227.17060047CS
4-1.525-18.07943094258.4358.696.7945146659047.69015438CS
12-1.69-19.65116279078.69.546.54170469507.71320554CS
264.6199.1341991342.3112.281.95257696586.93470536CS
523.62110.0303951373.2912.281.95174937125.75202083CS
1563.83124.3506493513.0812.281.2593526485.10359503CS
260-8.79-55.987261146515.716.0151.2164567085.06759973CS

IBRX - Frequently Asked Questions (FAQ)

What is the current ImmunityBio Inc share price?
The current share price of ImmunityBio Inc is US$ 6,91
How many ImmunityBio Inc shares are in issue?
ImmunityBio Inc has 1.047.353.977 shares in issue
What is the market cap of ImmunityBio Inc?
The market capitalisation of ImmunityBio Inc is USD 7,24B
What is the 1 year trading range for ImmunityBio Inc share price?
ImmunityBio Inc has traded in the range of US$ 1,95 to US$ 12,28 during the past year
What is the PE ratio of ImmunityBio Inc?
The price to earnings ratio of ImmunityBio Inc is -8,09
What is the cash to sales ratio of ImmunityBio Inc?
The cash to sales ratio of ImmunityBio Inc is 53,34
What is the registered address of ImmunityBio Inc?
The registered address for ImmunityBio Inc is 3530 John Hopkins Court, San Diego, California, 92121
What is the ImmunityBio Inc website address?
The website address for ImmunityBio Inc is immunitybio.com
Which industry sector does ImmunityBio Inc operate in?
ImmunityBio Inc operates in the Biotechnology & Life Sciences sector

IBRX Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock